The volatility ratio for the week is 8.02%, and the volatility levels for the last 30 days are 6.50% for Guardian Pharmacy Services Inc The simple moving average for the past 20 days is -6.76% for GRDN’s stock, with a 8.32% simple moving average for the past 200 days.
Is It Worth Investing in Guardian Pharmacy Services Inc (NYSE: GRDN) Right Now?
Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for GRDN is 9.13M, and at present, short sellers hold a 1.45% of that float. On December 26, 2024, the average trading volume of GRDN was 233.36K shares.
GRDN) stock’s latest price update
The stock of Guardian Pharmacy Services Inc (NYSE: GRDN) has decreased by -6.38 when compared to last closing price of 23.65.Despite this, the company has seen a loss of -1.77% in its stock price over the last five trading days. businesswire.com reported 2024-12-17 that ATLANTA–(BUSINESS WIRE)–Guardian Pharmacy Services (NYSE: GRDN) expands to New Jersey through partnership with long-term care pharmacy Freedom Pharmacy.
Analysts’ Opinion of GRDN
Many brokerage firms have already submitted their reports for GRDN stocks, with Truist repeating the rating for GRDN by listing it as a “Buy.” The predicted price for GRDN in the upcoming period, according to Truist is $22 based on the research report published on October 21, 2024 of the current year 2024.
Raymond James, on the other hand, stated in their research note that they expect to see GRDN reach a price target of $21. The rating they have provided for GRDN stocks is “Outperform” according to the report published on October 21st, 2024.
GRDN Trading at 4.16% from the 50-Day Moving Average
After a stumble in the market that brought GRDN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -13.97% of loss for the given period.
Volatility was left at 6.50%, however, over the last 30 days, the volatility rate increased by 8.02%, as shares sank -9.63% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +29.10% upper at present.
During the last 5 trading sessions, GRDN fell by -1.77%, in comparison to the 20-day moving average, which settled at $23.74. In addition, Guardian Pharmacy Services Inc saw 38.37% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GRDN starting from COSLER STEVEN D, who purchase 7,000 shares at the price of $21.22 back on Nov 19 ’24. After this action, COSLER STEVEN D now owns 17,713 shares of Guardian Pharmacy Services Inc, valued at $148,540 using the latest closing price.
Salentine Thomas J Jr, the Director of Guardian Pharmacy Services Inc, purchase 35,714 shares at $14.00 during a trade that took place back on Sep 27 ’24, which means that Salentine Thomas J Jr is holding 35,714 shares at $499,996 based on the most recent closing price.
Stock Fundamentals for GRDN
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.14.
Conclusion
To sum up, Guardian Pharmacy Services Inc (GRDN) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
